IFNL1 and melanoma: The A375 human melanoma cell line was treated for 48 hours with ixazomib (35 nM) in combination with IL-29 (100 ng/mL), PLX4720 (1 μM), or sorafenib (5 μM) and evaluated for levels of apoptosis as described previously (Figure 9).